HCPCS code C9053 — Inj, crizanlizumab-tmca. Status: Deleted. Effective Jul 1, 2020. Source: CMS HCPCS Level II.

C9053

Deleted

Inj, crizanlizumab-tmca

Injection, crizanlizumab-tmca, 1 mg

Code C9053 has been deleted from the HCPCS Level II set.

Termination date: Jun 30, 2020. Claims with a date of service on or after this day will be denied under this code.

No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.

Category: Outpatient PPS
Section: C-codes: Outpatient PPS
Effective: Jul 1, 2020
Terminated: Jun 30, 2020
Code type: alphanumeric

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2020-Q3
    Inj, crizanlizumab-tmca
  • Deleted 2020-Q2
    Inj, crizanlizumab-tmca